NM_015272.5:c.2959-32G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_015272.5(RPGRIP1L):​c.2959-32G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.322 in 1,132,226 control chromosomes in the GnomAD database, including 66,730 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). There are indicators that this mutation may affect the branch point..

Frequency

Genomes: 𝑓 0.39 ( 13699 hom., cov: 32)
Exomes 𝑓: 0.31 ( 53031 hom. )

Consequence

RPGRIP1L
NM_015272.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -0.0300

Publications

18 publications found
Variant links:
Genes affected
RPGRIP1L (HGNC:29168): (RPGRIP1 like) The protein encoded by this gene can localize to the basal body-centrosome complex or to primary cilia and centrosomes in ciliated cells. The encoded protein has been found to interact with nephrocystin-4. Defects in this gene are a cause of Joubert syndrome type 7 (JBTS7) and Meckel syndrome type 5 (MKS5). [provided by RefSeq, Jun 2016]
RPGRIP1L Gene-Disease associations (from GenCC):
  • Meckel syndrome, type 5
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • Joubert syndrome 7
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • COACH syndrome 1
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Joubert syndrome with renal defect
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Meckel syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
This position, referring to a specific DNA site, is a probable branch point but is likely benign (scored 0 / 10, using the threshold of <=3). The score ranges from 0 to 10, with values ≤3 considered benign and >5 classified as pathogenic. Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 16-53638443-C-T is Benign according to our data. Variant chr16-53638443-C-T is described in ClinVar as Benign. ClinVar VariationId is 126276.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.619 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RPGRIP1LNM_015272.5 linkc.2959-32G>A intron_variant Intron 19 of 26 ENST00000647211.2 NP_056087.2 Q68CZ1-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RPGRIP1LENST00000647211.2 linkc.2959-32G>A intron_variant Intron 19 of 26 NM_015272.5 ENSP00000493946.1 Q68CZ1-1

Frequencies

GnomAD3 genomes
AF:
0.393
AC:
59571
AN:
151608
Hom.:
13650
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.625
Gnomad AMI
AF:
0.227
Gnomad AMR
AF:
0.300
Gnomad ASJ
AF:
0.366
Gnomad EAS
AF:
0.587
Gnomad SAS
AF:
0.410
Gnomad FIN
AF:
0.179
Gnomad MID
AF:
0.503
Gnomad NFE
AF:
0.293
Gnomad OTH
AF:
0.397
GnomAD2 exomes
AF:
0.339
AC:
82446
AN:
243214
AF XY:
0.340
show subpopulations
Gnomad AFR exome
AF:
0.627
Gnomad AMR exome
AF:
0.226
Gnomad ASJ exome
AF:
0.406
Gnomad EAS exome
AF:
0.603
Gnomad FIN exome
AF:
0.183
Gnomad NFE exome
AF:
0.294
Gnomad OTH exome
AF:
0.341
GnomAD4 exome
AF:
0.311
AC:
305082
AN:
980502
Hom.:
53031
Cov.:
13
AF XY:
0.316
AC XY:
160478
AN XY:
508266
show subpopulations
African (AFR)
AF:
0.636
AC:
15214
AN:
23908
American (AMR)
AF:
0.230
AC:
10029
AN:
43546
Ashkenazi Jewish (ASJ)
AF:
0.401
AC:
9233
AN:
23030
East Asian (EAS)
AF:
0.551
AC:
20472
AN:
37172
South Asian (SAS)
AF:
0.407
AC:
30791
AN:
75662
European-Finnish (FIN)
AF:
0.186
AC:
9652
AN:
51968
Middle Eastern (MID)
AF:
0.499
AC:
2396
AN:
4798
European-Non Finnish (NFE)
AF:
0.283
AC:
191601
AN:
675878
Other (OTH)
AF:
0.352
AC:
15694
AN:
44540
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
9395
18791
28186
37582
46977
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4966
9932
14898
19864
24830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.393
AC:
59678
AN:
151724
Hom.:
13699
Cov.:
32
AF XY:
0.388
AC XY:
28798
AN XY:
74164
show subpopulations
African (AFR)
AF:
0.626
AC:
25917
AN:
41414
American (AMR)
AF:
0.299
AC:
4561
AN:
15234
Ashkenazi Jewish (ASJ)
AF:
0.366
AC:
1265
AN:
3458
East Asian (EAS)
AF:
0.587
AC:
3028
AN:
5162
South Asian (SAS)
AF:
0.410
AC:
1975
AN:
4818
European-Finnish (FIN)
AF:
0.179
AC:
1883
AN:
10526
Middle Eastern (MID)
AF:
0.500
AC:
146
AN:
292
European-Non Finnish (NFE)
AF:
0.293
AC:
19843
AN:
67798
Other (OTH)
AF:
0.404
AC:
853
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1674
3348
5022
6696
8370
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
562
1124
1686
2248
2810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.357
Hom.:
3856
Bravo
AF:
0.409
Asia WGS
AF:
0.500
AC:
1737
AN:
3466

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Joubert syndrome 7 Benign:1
Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Meckel syndrome, type 5 Benign:1
Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Meckel-Gruber syndrome;C0431399:Joubert syndrome Benign:1
Aug 12, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
8.7
DANN
Benign
0.39
PhyloP100
-0.030
BranchPoint Hunter
0.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.12
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7203525; hg19: chr16-53672355; COSMIC: COSV50902765; COSMIC: COSV50902765; API